CeZZ 77: 881-894, 1994; also, erratum in CeZZ 78: 1994) . The longest open-reading frame of PKDl encodes polycystin, a novel -460-kDa protein that contains a series of NHz-terminal adhesive domains (J. Hughes, C. J. Ward, B. Peral, R. Aspinwall, K. Clark, J. San Millan, V. Gamble, and P. C. Harris. Nat. Genet. 10: 151-160, 1995; and Int. PKD Consortium. CeZZ 81: 289-298,1995 ) and several putative transmembrane segments. To extend studies of polycystin to an experimentally accessible animal, we have isolated a cDNA clone encoding the 3' end of Pkdl, the mouse homologue of PKDl, and raised a specific antibody to recombinant murine polycystin. This antibody was used to determine the subcellular localization and tissue distribution of the protein by Western analysis and immunocytochemistry.
In the mouse, polycystin is an -400-kDa molecule that is predominantly found in membrane fractions of tissue and cell extracts. It is expressed in many tissues including kidney, liver, pancreas, heart, intestine, lung, and brain. Renal expression, which is confined to tubular epithelia, is highest in late fetal and early neonatal life and drops 20-fold by the third postnatal week, maintaining this level into adulthood. Thus the temporal profile of polycystin expression coincides with kidney tubule differentiation and maturation.
PKDl; polycystic kidney disease; kidney development; immunohistochemistry;
Western analysis RENAL EPITHELIAL CYST formation is the central pathophysiological feature in a host of congenital and acquired human diseases. Among these, autosomal dominant polycystic kidney disease (ADPKD) is the most common, affecting over 500,000 individuals in the United States. Viewed as a prototype, ADPKD is characterized by progressive focal dilatation of scattered tubular nephron segments, resulting in cystic replacement of normal renal parenchyma, and irreversible renal failure during adult life (7). Cysts can also be found in the liver and pancreas. Cyst formation has been associated with abnormal proliferative capacity of epithelial cells, loss of polarized epithelial phenotype, fluid accumulation resulting from abnormal secretion, and changes in extracellular matrix composition (2, 10, 18). Despite information emerging about the mutated gene products in this disorder (see below), the precise nature of the primary defects and the mechanisms that lead to cyst formation remain poorly understood. Likewise, although a large number of hereditary cystic diseases have been studied in rodents (8, 14, 20, 29, 30) , the mutated gene has only been identified in one model (20) , and study of these animals has not yet provided broad insights into the pathogenesis of renal cysts.
Mutations in at least three genetically distinct genes cause ADPKD. The PKDl and PKD2 genes are located on chromosomes 16 (28) and 4, respectively (6,17). The third locus has not been mapped (3). PKDl, which accounts for over 85% of ADPKD cases (7), has recently been identified (5). The longest open-reading frame encodes polycystin, an -4,300-residue protein whose NH2 terminus contains a signal peptide and a series of adhesive domains including two leucine-rich repeats, a C-type lectin domain, a low-density lipoprotein-A domain, and at least 13 tandem copies of a novel "PKD" domain (13, 15) . At the COOH terminus, there is a hydrophobic region containing 9-11 putative membrane-spanning segments and an intracellular segment of -200 residues (13, 15). More than a dozen mutations have been identified in PKDl, including deletions (5,25) and nonsense (32) and missense mutations (26). PKD2, which accounts for -10% of ADPKD cases, encodes a 968-residue protein containing six putative membrane-spanning segments with intracellular NH2 and COOH termini (19). There is -25% identity and -50% similarity between the PKD2 protein and a 450-amino acid stretch from the hydrophobic region of polycystin. The PKD2 protein shares homology with voltage-activated Ca2+ and Na+ channels (19). The functions of PKDl and PKD2 are not known.
Recent studies have shown that human polycystin is expressed in fetal and adult kidneys (9, 11, 34) and in a range of other tissues (9, 11). The level of polycystin is higher in fetal than in adult life (9). However, detailed study of the developmental regulation of this protein in humans is limited by the availability of staged tissues.
To learn how the structural features of polycystin contribute to its function and to obtain information on the effects of interactions with its ligand(s), it will be valuable to study an experimentally accessible animal, such as the mouse, in which genetic and surgical manipulations are possible and in which a wide range of tissues are available. Although naturally occurring mutations of the mouse homologue of PKDl have not been observed, these studies will also lay the groundwork for the study of polycystin in the large range of genetic, transgenic, and drug-induced models of polycystic kidney disease in the mouse (8, 14, 16, 30, 31 Earliest dissectable kidneys were from days 11.542 embryos (E11.5-ED) in which nondivided ureteric buds could be identified.
Total RNA was isolated from various stages of whole embryos or embryonic tissues and from adult mouse (3 mo old) as previously described (36). About 10 ug of total RNA represent the yield from lo-20 early embryonic kidneys. The Northern blots were probed with a 32P-labeled mouse Pkdl cDNAfragment homologous to the most 3' PKDl cDNA coding sequence. A 32P-labeled cDNA fragment of glyceraldehyde-3-phosphate dehydrogenase was used as a control probe to demonstrate equal loading of RNA in each lane. Membrane isolation from mouse tissues. Individual mouse embryos were dissected as described above. Various organs were homogenized in buffer [lo mM phosphate buffer, 20 mM KCl, 5% sucrose, 0.5 mM MgC12,l mM EDTA, 1 mM ethylene glycol-bis(P-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), 1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF), 5 ug/ml pepstatin A, 5 ug/ml antipain, and 2.5 ug/ml leupeptin].
Tissue homogenates were centrifuged successively at 1,000 g for 15 min, 8,000 g for 20 min, and 100,000 g for 2 h. Supernatant (SlOO) and pellet fractions (P8, pellet of 8,000 g; and PlOO, pellet of 100,000 g) were collected. Pellets were resuspended in the homogenization buffer, snap frozen in liquid nitrogen, and stored at -80°C. All steps were performed at 4°C. Protein concentrations were measured by the Bradford method.
Cell culture and preparation of inner medullary collecting duct cell membranes.
Inner medullary collecting duct (IMCD) cells (27) were grown to confluence in Dulbecco's modified Eagle's medium + Ham's F-12 with 10% fetal calf serum. The cells were washed three times in phosphate-buffered saline (PBS), scraped, and homogenized in buffer (5% sucrose, 20 mM Tris HCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, 5 ug/ml pepstatin A, 5 ug/ml antipain, and 2.5 ug/ml leupeptin).
Membrane fractions were isolated as described above.
Western blotting. Protein samples (5-10 ug of fusion proteins or 100-200 ug of tissue fractions) were solubilized in sample buffer [2% SDS, 30 mM Tris HCl, pH 6.8, 5% p-mercaptoethanol, and 12% (vol/vol) glycerol] and electrophoretitally fractionated on 5---10% SDS-PAGE nongradient gels after boiling. Proteins were electrotransferred to PVDF Immobilon membranes and blotted with specific antibodies (mpkcr-Ab at l:l,OOO dilution, purified antisera at 1:lO) in blotting buffer (5% nonfat dry milk in 0.15 M NaCl, 1% Triton X-100, and 20 mM Tris HCl, pH 7.4). After several washes, the membranes were incubated with peroxidase-conjugated secondary antibody and detected by enhanced chemiluminescence (ECL, Amersham).
lmmunocytochemistry. Immunocytochemistry was carried out as previously described (24). Tissues embedded in OCT optimal cutting temperature compound (Miles, Elkhart, IN) were cross sectioned at 5 urn in a cryostat at -2OOC. Sections were air dried for 30 min and then fixed in acetone for 5 min. After brief air drying, sections were rinsed three times in PBS and incubated with 20 ul of primary antibody for 1 h. Mpkcr-Ab antisera were used at a dilution of 1:lOO. Control sections were incubated with preimmune serum at the same concentration.
For antigen-blocking experiments, antibodies were preincubated with a specific antigen (either in solution or on an immunoblot) for 1 h at room temperature. After washing, the sections were incubated for 45 min with 20 ul of fluorescein isothiocyanate-conjugated goat anti-rabbit immunoglobulin G (IgG; Sigma Chemical, St. Louis, MO) for 30 min at room temperature, mounted in glycerol and PBS, and observed with epifluorescent illumination. Immunoperoxidase staining was carried out using the Vectastain Elite ABC kit (Vector, Burlingame, CA) containing avidin and biotinylated horseradish peroxidase. Primary polyclonal antibodies were diluted to 1:500. Biotinylated goat anti-rabbit IgG (Vector) were used as secondary antibodies. Diaminobenzidine tetrahydrochloride was used as a chromogen, and methyl green or hematoxylin was used for counterstaining (Sigma). Photographs were taken with a Nikon 200 and Kodak 25 IS0 color film.
RESULTS
The mouse homologue of polycystin. A mouse fetal kidney cDNA library was screened with human PKDl cDNA clones (Lohning et al., unpublished observations) . One of the mouse clones, MC82, hybridized to the 3' end of PKDl and contained an open-reading frame that encodes a peptide with 77% sequence identity and 84% sequence similarity to the COOH terminus of human polycystin (13, 15) (Fig. 1) Fig. 1 ). Following cleavage of the fusion protein, mpkcr-Ab reacted strongly with mpkcr (data not shown). Mpkcr-Ab detected an -4OOkDa band on immunoblots of mouse embryonic kidney tissue. This protein is indistinguishable in size from the protein detected in human tissue extracts by two anti-human polycystin antibodies (9). The reactivity of mpkcr-Ab with the 400-kDa protein was blocked by preadsorption with mpkcr but not with MBP alone, demonstrating that immunoreactivity is specific to polycystin (Fig. 2) . Preimmune serum did not react with mouse embryonic kidney tissue extracts (Fig. 2) . Trace reactivity of mpkcr-Ab with 200-and 70-kDa bands was observed, although the 200-kDa band can scarcely be seen on photographic reproductions. The intensity of these bands varied greatly between experiments. Reactivity of mpkcr-Ab with the 200kDa band was blocked by mpkcr (Fig. 2) . These data suggest that the 200-kDa protein is likely to be a proteolytic product of full-length polycystin.
The Pkdl transcript. Northern analysis was carried out to evaluate the size of the predominant Pkdl transcript and to investigate the possibility of splice variants accounting for the 200-and 70-kDa bands. Using the MC82 probe to study embryonic day 18 U318) and adult mouse kidneys as well as various stages of whole embryos, we detected a single band of -14 kb, even after prolonged autoradiography (Fig. 3) . The Pkdl transcript was first detected in total mouse embryos at day 10.5, the earliest stage we examined. We could not detect any signal in El8 or adult livers on three separate Northern blots (Fig. 3) , indicating that the level of Pkdl mRNAin liver is much lower than that in kidneys in mice of the same age. The absence of multiple bands on the Northern blots suggests that alternatively spliced transcripts containing the extreme 3' end of Pkdl are not abundant, at least in the stages and tissues we examined. The Pkdl transcript is similar in size to the human PKDl mRNA.
Murine polycystin is membrane-associated and expressed in many tissues. By both reverse transcriptionpolymerase chain reaction and Western analyses it was found that IMCD cells, derived from mouse IMCDs, expressed polycystin at high levels. These cells are able to form polarized monolayers and tubular structures in vitro. IMCD cells might therefore provide a model system for the exploration of the role of polycystin in cell differentiation and tubulogenesis and were therefore used to determine the subcellular localization of the protein (Fig. 4A) . Polycystin was found in mem--4OO+ 12345676 Fig. 2 . Characterization of an anti-murine polycystin antibody Embryonic day 18 (El8) and newborn (NB) mouse kidney tissues C-200 pg of PlOO fraction) were blotted with rabbit anti-mouse polyclonal antibody mpkcr-Ab (83, lanes 1 and 2); with mpkcr-Ab that had been preadsorbed with maltose binding protein (MBP) (83+mbp, lanes 3 and 4); with mpkcr-Ab that had been preadsorbed with its immunogen, mpkcr (83+mpkcr, lanes 5 and 6); and with preimmune sera (pre-83, lanes 7 and 8). Molecular mass markers are indicated on left. Mpkcr-Ab detects a protein of -400 kDa (arrow). Reactivity of mpkcr-Ab with the 400kDa protein was blocked by mpckr, a specific antigen, but not by MBF! brane fractions but not in cytosolic fractions of IMCD cells (Fig. 4A) . It was also found in PlOO membrane fractions of tissue extracts from kidney (Figs. 2 and 4B ) and other organs including heart, brain, liver, lung, pancreas, and small intestine (Fig. 4B) . These findings suggest that murine polycystin is either an integral membrane protein, as has been proposed for human polycystin based on the deduced protein sequence (13), or is a protein that is closely associated with the cell plasma membrane or with intracellular membranes or organelles.
Developmental regulation ofpolycystin expression. To determine the developmental profile of murine polycystin expression, fetal and neonatal kidneys from El2 to birth were studied by Northern analysis. A Pkdl transcript was first identified at El4 when nephrogenic induction is still a major event in kidney development, but the greatest expression was observed between El6 and El9 when nephrogenic induction is complete. In the adult mouse, transcript levels were significantly lower than in late fetal life (Figs. 3 and 5) .
Western analysis was carried out in mouse embryos from E10.5-E17.5 and in kidneys from El4 to adulthood. Polycystin levels are highest in mouse embryos on El03 and decrease thereafter (Fig. 6) . In the kidney, a high level of expression was detected on El4 through 1 wk after birth (Fig. 6) . Between the first and the second postnatal weeks the level of expression drops by at least sixfold (Fig. 6) . With prolonged exposure of autoradiographs, a very faint band (>20-fold weaker) was detected in mice older than 3 wk into adulthood, indicating that a very low level of murine polycystin expression is maintained throughout life. The intensity of the 70-kDa protein decreases in a similar manner. At 1 wk after birth, a new 45kDa band appears and increases in intensity as polycystin expression decreases. The nature of this 45kDa band requires further investigation.
Two mouse strains (CD1 and BALB/c) were compared; the temporal and spatial expression patterns were similar in both strains (data not shown).
Mouse polycystin expression is restricted to tubular epithelial cells in the kidney. To determine the spatial and temporal patterns of polycystin expression within the kidney, immunocytochemistry was performed on E10.5 through newborn, postnatal (from week 1 to 8)
A 6 ***ri$ were clearly stained in kidneys earlier than E13.5, although immunoperoxidase reactivity was clearly above background level. During the subsequent differentiation stages, staining became concentrated in the epithelial structures. In kidneys of E15.5, polycystin was clearly detected in the ureteric bud, collecting tubules, and renal pelvis (Fig. 7, A-E) . Staining was weakest in the tip of the bud, suggesting that polycystin does not have a major role in nephrogenie induction (Fig. 7A) . No signals were detected in mesenchyme-derived structures at early (condensates, comma-and S-shaped bodies) (Fig. 7B) or late stages of differentiation (tubule elongation) of renal tubulogenesis (21). Polycystin was also absent from uninduced mesenchyme itself (Fig. 7A) , differentiated stroma (Fig.  701 , and developing and mature glomeruli (Fig. 7 , B and C). In El8 kidneys, high levels of expression were also observed in the collecting duct system, the papillae, and the renal pelvis (Fig. 7F) , which are all derived from the ureter, and in the ureter itself (23). Within the collecting duct system, polycystin was found in both papillary ducts that are situated in the medulla of the kidney and in the straight collecting ducts of the kidney periphery. The level of expression in the papillae was slightly weaker than that in the collecting ducts in the outer medulla (Fig. 7F) ; this difference became more evident in the newborn kidney (Fig. 7G) . No immunoreactivity was detected in endothelial or smooth muscle cells in renal vessels.
Levels and distribution of polycystin in kidneys from newborn ( Fig. 7G ) and 1-wk-old mice (Fig. 7, H and 1) were indistinguishable from those of El8 kidneys by immunostaining.
After the first postnatal week, epithelial staining decreased gradually, and by postnatal day 21, staining of the collecting system decreased to a very low level that was just above background levels. The low level of staining seen at day 21 was maintained through adulthood (Fig. 7J) .
Polycystin expression in other organs. Polycystin expression was also investigated in other organs, including the liver, pancreas, heart, small intestine, brain, and spleen (Fig. 8) . Polycystin was found in the hepatic bile ducts and pancreatic ducts (Fig. 8, A and B) . Weak staining in the acinar cells was noted. The protein was also found in villi of the small intestine, choroid plexus and ependyma in the brain, and bronchioles in the lung (Fig. 8, C , E, and F). Although in most organs expression was restricted to epithelia, a low level of expression was observed in the myocardium (Fig. 80) . Vascular endothelial cells were consistently negative. We did not detect polycystin in the spleen (data not shown).
DISCUSSION
Although polycystin, the product of the human PKDl gene, contains several recognizable protein motifs, including NHz-terminal adhesive domains and several probable transmembrane domains, the overall structure of the molecule is unlike any known protein, precluding a provisional assignment of its function. Many of the most powerful approaches to understanding the function of polycystin and the pathophysiology of renal cystic diseases require the development of model systems in which the interactions of polycystin can be studied. The aims of this study were to demonstrate that the distribution of murine polycystin at the cellular and tissue levels is similar to that of the human protein and to better define the developmental profile of polycystin expression during fetal and neonatal life. We 1 2 3 4 5 6 7 8 9101112 131415161718192021 have therefore isolated a portion of a mouse gene, which we have designated Pkdl, whose deduced peptide sequence has 84% similarity to human polycystin and which has a transcript of a similar size. An antibody raised to recombinant murine polycystin was used to carry out a survey of its distribution in developing and mature mouse tissues at the transcript and protein levels.
The human and murine proteins were found to have predominant isoforms of -400 kDa. Furthermore, we show that spatial and temporal distribution as well as subcellular localization of polycystin in the murine kidney is in broad agreement with the findings in humans (9, 11, 341 . This study also shows that polycystin is widely expressed in a number of tissues other than the kidney, in agreement with our previous human studies (9). These similarities provide the basis for using the mouse as a model for the study of the physiology and pathophysiology of polycystin. Our analyses of the levels of the transcript and native protein reveal that murine polycystin has a distinct stage-and cell-specific expression pattern. In the developing kidney, polycystin expression is weakest in the tip of the ureteric bud (Fig. 7A ), suggesting that it is unlikely to be required for nephrogenic induction (4). It is, however, strongly expressed in structures derived from the ureter, including straight collecting ducts, papillary ducts, and the renal pelvis. Papillary ducts represent a later developmental stage than straight collecting ducts, since they are formed during the first cycles of branching of the ingrowing ureter (23). Cells from ureter-derived structures divide rather slowly as judged by bromodeoxyuridine immunohistochemistry (22). In fact papillary duct cells cease dividing by El5 (22) . A high level of polycystin expression was seen in papillary collecting ducts and the renal pelvis in late kidney development (El8 and newborn), suggesting that polycystin expression does not simply occur, if all other things are equal, with tubule cell proliferation. Polycystin expression continues in tubular epithelia after birth but, by the third postnatal week, falls to a low level that is maintained into adult life. It is known that anatomic and functional maturity of the collecting ducts is not complete until 21-30 days after birth. For example, microperfusion studies of Na-transport show that maturation of collecting duct occurs in two stages, i.e., a decrease in passive Na * permeability to mature levels by 2 wk due to formation of tight junctions, F458 IDENTITY AND CHARACTER OF MURINE PKDl GENE PRODUCT followed by an increase in active Na+ transport that begins after 2 wk and approaches adult levels at 3 wk (33 
